載入...
Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
BACKGROUND: Topotecan is the standard second line agent used in relapsed small cell lung cancer (SCLC). However, the erratic availability and the cost of the drug has been a prohibitive factor for its use in second-line setting in India. Paclitaxel has shown antitumor activity in heavily pretreated...
Na minha lista:
| 發表在: | South Asian J Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Medknow Publications & Media Pvt Ltd
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4873701/ https://ncbi.nlm.nih.gov/pubmed/27275452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.181643 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|